Search | Page 37 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. A Phase I Study to Assess the Safety APL-2 as an Add-On to Standard of Care in Subjects With PNH

    ... Disease(s):  paroxysmal nocturnal hemoglobinuria (PNH) Phase:  ...

    Clinical Trial last updated 08/24/2016 - 11:15am.

  2. Recurrent and Secondary MDS

    ...

    Interview last updated 10/24/2012 - 1:12pm.

  3. Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET)

    ... > 1.5 mg/ml No detectable PNH ( paroxysmal nocturnal hemoglobinuria ) clone where tested Concurrent hormonal ...

    Clinical Trial last updated 04/29/2016 - 9:59am.

  4. Eltrombopag now an approved therapy for certain patients with severe aplastic anemia

    ... this have on patients with SAA and paroxysmal nocturnal hemoglobinuria (PNH)? “In the initial study, we excluded patients with ...

    Page last updated 08/27/2014 - 2:19pm.

  5. ASH 2012 - Reviewing MDS Progress from Research and Clinical Perspectives

    ...

    Interview last updated 02/07/2013 - 1:28pm.

  6. American Society of Hematology Annual Meeting 2014

    ... most important research about PNH ( paroxysmal nocturnal hemoglobinuria ) reported at the 2014 American Society of Hematology Annual ...

    Page last updated 03/11/2015 - 3:10pm.

  7. PNH Studies Summary Report: I-PIG Meeting ASH 2014

    ... shortness of breath, headaches, bruising or bleeding and hemoglobinuria . Our data showed the majority of participants were able to ...

    Page last updated 12/11/2014 - 10:47am.

  8. ASH 2012 - Reviewing MDS Progress from Research and Clinical Perspectives

    ...

    Interview last updated 02/01/2013 - 4:22pm.

  9. Recommended Reading

    ...

    Page last updated 05/07/2013 - 1:41pm.

  10. Coordinated Care: MDS Research and Treatment Centers and Community Hematologists Work Together for Complete Patient Care

    ...

    Interview last updated 07/23/2012 - 4:56pm.